China Money Network
Login
Join

Hillhouse-Backed BeiGene Completes $158M US IPO

  • February 4, 2016 — 13:00 CST

This Data Is Locked!

This area is available only to Subscribers.

Beijing-based cancer drug developer BeiGene (Beijing) Co., Ltd., backed by Hillhouse Capital and CITIC Private Equity, has completed an initial public offering in the U.S.,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: